- Report
- September 2026
- 427 Pages
Global
From €5211EUR$5,850USD£4,479GBP
- Report
- January 2026
- 220 Pages
Global
From €3118EUR$3,500USD£2,680GBP
- Report
- July 2026
- 114 Pages
Global
From €4231EUR$4,750USD£3,637GBP
- Report
- July 2026
- 180 Pages
Global
From €4231EUR$4,750USD£3,637GBP
- Report
- January 2026
- 280 Pages
Global
From €2672EUR$3,000USD£2,297GBP
- Report
- July 2026
- 165 Pages
Global
From €4231EUR$4,750USD£3,637GBP
- Report
- May 2026
- 146 Pages
Global
From €3518EUR$3,950USD£3,025GBP
- Report
- May 2026
- 156 Pages
Global
From €3518EUR$3,950USD£3,025GBP
- Report
- July 2026
- 160 Pages
Global
From €2957EUR$3,320USD£2,542GBP
€3697EUR$4,150USD£3,178GBP
- Report
- July 2026
- 160 Pages
Global
From €2957EUR$3,320USD£2,542GBP
€3697EUR$4,150USD£3,178GBP
- Report
- April 2026
- 160 Pages
Global
From €2957EUR$3,320USD£2,542GBP
€3697EUR$4,150USD£3,178GBP
- Report
- February 2026
- 160 Pages
Global
From €2957EUR$3,320USD£2,542GBP
€3697EUR$4,150USD£3,178GBP
- Report
- October 2025
- 160 Pages
Global
From €2815EUR$3,160USD£2,420GBP
€3518EUR$3,950USD£3,025GBP
- Report
- July 2026
- 134 Pages
Global
From €4320EUR$4,850USD£3,714GBP
- Report
- November 2025
- 87 Pages
Global
From €3500EUR$4,209USD£3,114GBP
- Report
- September 2025
- 150 Pages
Global
From €4320EUR$4,850USD£3,714GBP
- Report
- January 2026
- 150 Pages
Global
From €4320EUR$4,850USD£3,714GBP
- Report
- September 2024
- 351 Pages
Global
From €3738EUR$4,197USD£3,214GBP
- Report
- April 2023
- 52 Pages
Global
From €4454EUR$5,000USD£3,829GBP
- Report
- August 2026
- 423 Pages
From €4275EUR$4,799USD£3,675GBP

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more